AJP - Lung Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 295: L44-L53, 2008. First published April 25, 2008; doi:10.1152/ajplung.00448.2007
1040-0605/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
295/1/L44    most recent
00448.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petrache, I.
Right arrow Articles by Tuder, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrache, I.
Right arrow Articles by Tuder, R. M.

Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide

Irina Petrache,1,2,3 Terry R. Medler,3 Amy T. Richter,2 Krzysztof Kamocki,1 Ugonma Chukwueke,2 Lijie Zhen,2 Yuan Gu,1 Jeremy Adamowicz,1 Kelly S. Schweitzer,1 Walter C. Hubbard,4 Evgeny V. Berdyshev,5 Giuseppe Lungarella,6 and Rubin M. Tuder2,3

1Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Indiana University, Indianapolis, Indiana; Divisions of 2Cardiopulmonary Pathology, Department of Pathology, 3Pulmonary and Critical Care Medicine, Department of Medicine, and 4Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Division of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois; and 6Department of Physiopathology and Experimental Medicine, University of Siena, Siena, Italy

Submitted 29 October 2007 ; accepted in final form 9 April 2008

The molecular events leading to emphysema development include generation of oxidative stress and alveolar cell apoptosis. Oxidative stress upregulates ceramides, proapoptotic signaling sphingolipids that trigger further oxidative stress and alveolar space enlargement, as shown in an experimental model of emphysema due to VEGF blockade. As alveolar cell apoptosis and oxidative stress mutually interact to mediate alveolar destruction, we hypothesized that the oxidative stress generated by ceramide is required for its pathogenic effect on lung alveoli. To model the direct lung effects of ceramide, mice received ceramide intratracheally (Cer12:0 or Cer8:0; 1 mg/kg) or vehicle. Apoptosis was inhibited with a general caspase inhibitor. Ceramide augmentation shown to mimic levels found in human emphysema lungs increased oxidative stress, and decreased, independently of caspase activation, the lung superoxide dismutase activity at 48 h. In contrast to their wild-type littermates, transgenic mice overexpressing human Cu/Zn SOD were significantly protected from ceramide-induced superoxide production, apoptosis, and air space enlargement. Activation of lung acid sphingomyelinase in response to ceramide treatment was abolished in the Cu/Zn SOD transgenic mice. Since cigarette smoke-induced emphysema in mice is similarly ameliorated by the Cu/Zn SOD overexpression, we hypothesized that cigarette smoke may induce ceramides in the mouse lung. Utilizing tandem mass spectrometry, we documented increased lung ceramides in adult mice exposed to cigarette smoke for 4 wk. In conclusion, ceramide-induced superoxide accumulation in the lung may be a critical step in ceramide's proapoptotic effect in the lung. This work implicates excessive lung ceramides as amplifiers of lung injury through redox-dependent mechanisms.

sphingolipids; cell death; lung; oxidative stress



Address for reprint requests and other correspondence: I. Petrache, Indiana Univ., Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Van Nuys Medical Science Bldg., 635 Barnhill Drive, MS224, Indianapolis, IN 46202-5120 (e-mail: ipetrach{at}iupui.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Levy, E. Khan, M. Careaga, and T. Goldkorn
Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death
Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L125 - L133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Uhlig and E. Gulbins
Sphingolipids in the Lungs
Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1100 - 1114.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.